Beatriz Rodríguez Miquel (Beatriz Rodriguez-Miquel)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Mycobacterium Tuberculosis

Replacement Therapy

Top Venues

Science advances

Chemical science

Chemical communications (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Mariska de Munnik, Pauline A Lang, Francisco De Dios Anton, Mónica Cacho, Robert H Bates, Jürgen Brem, Beatriz Rodríguez Miquel, Christopher J Schofield
High-throughput screen with the l,d-transpeptidase Ldt Mt2 of Mycobacterium tuberculosis reveals novel classes of covalently reacting inhibitors. Chemical science 14 (26) (2023)
Mariska de Munnik, Jasper Lithgow, Lennart Brewitz, Kirsten E Christensen, Robert H Bates, Beatriz Rodríguez Miquel, Christopher J Schofield
αβ,α'β'-Diepoxyketones are mechanism-based inhibitors of nucleophilic cysteine enzymes. Chemical communications (Cambridge, England) (2023)
Noton K Dutta, Lee G Klinkenberg, Maria-Jesus Vazquez, Delfina Segura-Carro, Gonzalo Colmenarejo, Fernando Ramon, Beatriz Rodríguez Miquel, Lydia Mata-Cantero, Esther Porras-De Francisco, Yu-Min Chuang, Harvey Rubin, Jae Jin Lee, Hyungjin Eoh, Joel S Bader, Esther Perez-Herran, Alfonso Mendoza-Losana, Petros C Karakousis
Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence. Science advances 5 (3) (2019)